TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from NewcelX ( (NCEL) ) is now available.
NewcelX Ltd., a company involved in a merger between NLS Pharmaceutics Ltd. and Kadimastem Ltd., announced the appointment of Mr. Omri Hagai as its new Chief Financial Officer, effective December 10, 2025. This appointment follows the resignation of the interim CFO, Mr. Uri Ben Or, and is not due to any disagreements within the company. Mr. Hagai brings significant experience from his previous roles in public companies across the technology and industrial sectors, which is expected to strengthen NewcelX’s financial leadership.
More about NewcelX
Average Trading Volume: 180,091
Technical Sentiment Signal: Sell
Current Market Cap: $2M
See more data about NCEL stock on TipRanks’ Stock Analysis page.